Vyvanse Capsule (2019-08-08)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Vyvanse 20 mg Capsule
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| AG4982B | Vyvanse 20 mg Capsule | - Recalling Firm
- Shire Pharma Canada ULC
- 22 Adelaide St West, Suite 3800
- Toronto
- M5H 4E3
- Ontario
- CANADA
- Marketing Authorization Holder
- Shire Pharma Canada ULC
- 22 Adelaide St West, Suite 3800
- Toronto
- M5H 4E3
- Ontario
- CANADA
| Capsule | DIN 02347156 | Lisdexamfetamine dimesylate 20 mg |
The dissolution in the affected lot is out of specification.